Table 1.
Frequency of clinical trial phases reviewed by FMASU REC from April to October 2020.
| Study Design | Number of protocols | Frequency of protocols |
|---|---|---|
| Randomized controlled trials | ||
| RCT Phase II | 2 | 0.52% |
| RCT Phase III | 15 | 5.85% |
| Total RCT | 17 | 6.37% |
| Observational studies | ||
| Cross-sectional study | 52 | 54.10% |
| Case control study | 5 | 5.85% |
| Cohort study | 13 | 16.91% |
| Total observational studies | 70 | 76.86% |
| Miscellaneous | ||
| Exploratory | 4 | 3.64% |
| Diagnostic | 3 | 4.68% |
| Registry | 2 | 3.90% |
| Systematic review | 1 | 2.21% |
| Review article | 1 | 2.34% |
| Total miscellaneous | 11 | 16.77% |
| Total | 98 | 100.00 |